Preseverance Clone
Preseverance Clone, licence 80135442: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- First Response Supplements
- NPN or DIN-HM
- 80135442
- Status
- Active licence
- Licence date
- 25 October 2024
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-(Aminoiminométhyl)-N-méthylglycine monohydraté Source : Créatine monohydratée | 1250.0 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 25.0 Microgrammes | Not calculated |
| Potassium Source : Chlorure de potassium | 100.0 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 62.5 mg | Not calculated |
| Niacine Source : Niacinamide | 25.0 mg | Not calculated |
| Calcium Source : Carbonate de calcium | 20.0 mg | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 1000.0 mg | Not calculated |
| Acide bêta-aminopropionique Source : Beta-alanine | 1600.0 mg | Not calculated |
| 1,3,7-Triméthylxanthine Source : Caféine | 150.0 mg | Not calculated |
| L-Tyrosine Source : L-Tyrosine | 750.0 mg | Not calculated |
| Choline Source : Choline | 100.0 mg | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 300.0 mg | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine | 100.0 mg | Not calculated |
| 4-hydroxy-alpha-[(méthylamino)méthyl]benzèneméthanol Source : Citrus aurantium - Fruit peel | 25.0 mg | Not calculated |
| 1,2,3-propanetriol Source : Glycérol | 1000.0 mg | Not calculated |
| 1-Amino-4-guanidinobutane Source : Sulfate d'agmatine | 427.0 mg | Not calculated |
Non-medicinal ingredients
Acide D-malique, Saveur, Citrate de sodium, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Mesures | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps (temporarily) to enhance (physical) energy. Helps (temporarily) to relieve/reduce fatigue, to promote endurance, and to enhance motor performance. Helps (temporarily) to relieve/reduce fatigue/tiredness. Source of (an) (non-essential) amino acid(s) involved in muscle protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80135442
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.